BIOMAT Database Logo BIOMAT Database Logo

Macrophage-derived cytokines in the cerebrospinal fluid of HIV-1-infected patients. 1990

P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
University of Padova, School of Medicine, Institute of Neurology.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D001685 Biological Factors Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS. Biologic Factors,Biological Factor,Factor, Biologic,Factor, Biological,Factors, Biological,Biologic Factor,Factors, Biologic
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Indinavir in cerebrospinal fluid of HIV-1-infected patients.
January 1997, Lancet (London, England),
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.
November 2009, AIDS (London, England),
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients.
March 1998, AIDS (London, England),
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
December 2000, Journal of acquired immune deficiency syndromes (1999),
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Cerebrospinal fluid catecholamine metabolites in HIV-infected patients.
March 1991, Journal of neuroscience research,
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment.
November 2007, Journal of proteome research,
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients.
September 2003, Journal of clinical pharmacology,
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Endothelin-1 is elevated in the cerebrospinal fluid of HIV-infected patients with encephalopathy.
January 1999, Infection,
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients.
December 2010, Journal of acquired immune deficiency syndromes (1999),
P Gallo, and A M Laverda, and A De Rossi, and S Pagni, and P Cogo, and V Argentiero, and E Francavilla, and M G Piccinno, and A del Mistro, and P Cadrobbi
Genetic attributes of cerebrospinal fluid-derived HIV-1 env.
July 2006, Brain : a journal of neurology,
Copied contents to your clipboard!